Format

Send to

Choose Destination
Biochem Biophys Res Commun. 2004 Nov 12;324(2):661-6.

Molecular models of cyclin-dependent kinase 1 complexed with inhibitors.

Author information

1
Departamento de Física, UNESP, São José do Rio Preto, SP. 15054-000, Brazil; Programa de Pós-Graduação em Biofísica Molecular-UNESP, São José do Rio Preto, SP 15054-000, Brazil. canduri@df.ibilce.unesp.br

Abstract

Roscovitine and flavopiridol have been shown to potently inhibit cyclin-dependent kinase 1 and 2 (CDK1 and 2). The structures of CDK2 complexed with roscovitine and deschoroflavopiridol have been reported, however no crystallographic structure is available for complexes of CDK1 with inhibitors. The present work describes two molecular models for the binary complexes CDK1:roscovitine and CDK1:flavopiridol. These structural models indicate that both inhibitors strongly bind to the ATP-binding pocket of CDK1 and structural comparison of the CDK complexes correlates the structures with differences in inhibition of these CDKs by flavopiridol and roscovitine. This article explains the structural basis for the observed differences in activity of these inhibitors.

PMID:
15474478
DOI:
10.1016/j.bbrc.2004.09.109
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center